Evidence map›Paper›PMID 40963912›Full record

Observational studyTheranostics2025

Pilot experience of [

Florian Rosar, Caroline Burgard, Christine Petrescu, Arne Blickle, Mark Bartholomä, Stephan Maus, Moritz B Bastian, Tilman Speicher, Andrea Schaefer-Schuler, Samer Ezziddin

Abstract readObservational Study
In one paragraph

Observational study in Theranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Beyond [BMC cancer · 2026
    Pooled it
  2. Efficacy and safety of [Frontiers in medicine · 2026
    Pooled it
  3. Organ and tumor dosimetry of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Tolerability of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  5. ImprovedACS omega · 2026
    Article
  6. Observational
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Florian RosarDepartment of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany.
Caroline BurgardDepartment of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany.
Christine PetrescuDepartment of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany.
Arne BlickleDepartment of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany.
Mark BartholomäDepartment of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany.
Stephan MausDepartment of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany.
Moritz B BastianDepartment of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany.
Tilman SpeicherDepartment of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany.
Andrea Schaefer-SchulerDepartment of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany.
Samer EzziddinDepartment of Nuclear Medicine, Saarland University - Medical Center, Homburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DipeptidesHeterocyclic Compounds, 1-RingProstatic Neoplasms, Castration-ResistantRadioisotopesRadiopharmaceuticalsTerbiumAgedAged, 80 and overHumansLutetiumMaleMiddle AgedPilot ProjectsProspective StudiesProstate-Specific AntigenRegistriesDipeptidesHeterocyclic Compounds, 1-RingLutetiumProstate-Specific AntigenPSMA-617RadioisotopesRadiopharmaceuticalsTerbium161TbmCRPCprostate cancerPSMAradioligand therapyRLTTb-161terbium-161

Identifiers

PMID40963912
PMCPMC12439265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.